Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
PMV Pharmaceuticals, Inc. (PMVP) had Return on Tangible Equity of -33.34% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-58.71M |
|
-- |
|
-- |
|
$85.45M |
|
$-85.45M |
|
$10.64M |
|
$-74.81M |
|
$-74.81M |
|
$-58.71M |
|
$-58.71M |
|
$-58.71M |
|
$-58.71M |
|
$-85.45M |
|
$-89.67M |
|
51.58M |
|
51.58M |
|
$-1.14 |
|
$-1.14 |
|
| Balance Sheet Financials | |
$175.66M |
|
$0.41M |
|
$15.63M |
|
$191.29M |
|
$14.37M |
|
-- |
|
$0.84M |
|
$15.21M |
|
$176.08M |
|
$176.08M |
|
$176.08M |
|
51.94M |
|
| Cash Flow Statement Financials | |
$-51.28M |
|
$53.35M |
|
$0.31M |
|
$38.53M |
|
$40.88M |
|
$2.35M |
|
$8.87M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.22 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-51.69M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-33.34% |
|
|
Return on Tangible Equity |
-33.34% |
-30.69% |
|
-33.34% |
|
$3.39 |
|
$-1.00 |
|
$-0.99 |
|